Position in RPRX
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$27,522,594
+$1,965,481 QoQ
Shares Held
573,746
-13.3% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Aberdeen Group plc holds $1,803,580,461 across 84 Biotechnology names. RPRX ranks #22 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
233,480 | $104,258,157 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
121,344 | $93,755,226 | |
| 3 | IMUX |
Immunic, Inc.
|
8,243,941 | $91,507,745 | |
| 4 | QURE |
uniQure N.V.
|
5,306,386 | $86,759,411 | |
| 5 | MANE |
Veradermics, Inc
|
1,054,660 | $66,601,779 | |
| 6 | ARGX |
Argenx SE
|
82,106 | $59,957,906 | |
| 7 | PCVX |
Vaxcyte, Inc.
|
978,969 | $56,887,888 | |
| 8 | PRAX |
Praxis Precision Medicines, Inc.
|
172,484 | $55,572,619 |
All Filings in RPRX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $27,522,594 | 573,746 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $25,557,113 | 661,416 | Shares | Defined | 2026-01-16 | |
| 2025-09-30 | $19,870,576 | 563,225 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $8,241,717 | 228,746 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $6,657,460 | 213,860 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,287,404 | 89,667 | Shares | Defined | 2025-01-24 | |
| 2024-09-30 | $2,952,117 | 104,352 | Shares | Defined | 2024-10-25 | |
| 2024-06-30 | $31,327,795 | 1,188,009 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $39,432,407 | 1,298,400 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $35,319,465 | 1,257,368 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $100,571,855 | 3,705,669 | Shares | Defined | 2023-11-07 | |
| 2023-06-30 | $119,122,202 | 3,875,153 | Shares | Defined | 2024-06-20 | |
| 2023-03-31 | $143,342,291 | 3,978,415 | Shares | Defined | 2024-06-20 | |
| 2022-12-31 | $139,010,688 | 3,517,477 | Shares | Defined | 2024-06-20 | |
| 2022-09-30 | $137,981,011 | 3,434,072 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $149,952,221 | 3,566,894 | Shares | Defined | 2022-08-05 | |
| 2022-03-31 | $87,236,502 | 2,239,130 | Shares | Defined | 2022-05-04 | |
| 2021-12-31 | $91,093,073 | 2,285,899 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $65,093,378 | 1,801,145 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $77,225,608 | 1,884,011 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $1,248,535 | 28,623 | Shares | Defined | 2021-05-06 | |
| 2020-12-31 | $510,660 | 10,203 | Shares | Defined | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||